Hainan Shuangcheng Pharmaceuticals Co., Ltd.
SHZ: 002693.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jianming Li
- Employees
- 474
- Headquarters
- Haikou, China
- IPO year
- 2012
- Market cap
- CN¥4.0B
- Website
- https://www.shuangchengmed.com
Loading 002693…
Loading profile data…Frequently asked questions about 002693
What does Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) do?
Hainan Shuangcheng Pharmaceuticals Co., Ltd. researches, develops, manufactures, and markets synthesized peptide drugs and active pharmaceutical ingredients worldwide. It offers somatostatin, thymosin, clindamycin hydrochloride, thymopentin, L-carnitine, uranin hydrobromide, inosine, cyclophosphine adenosine, motidine, scopolamine, and sodium fe...
Where does 002693.SZ trade?
Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002693.SZ in?
Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Hainan Shuangcheng Pharmaceuticals Co., Ltd.?
Jianming Li is the chief executive officer of Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ).
Where is Hainan Shuangcheng Pharmaceuticals Co., Ltd. headquartered?
Hainan Shuangcheng Pharmaceuticals Co., Ltd. is headquartered in China.
Does 002693.SZ pay a dividend?
Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 002693.SZ go public?
Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) completed its initial public offering in 2012.